Crossmark

Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin

Crossref DOI link: https://doi.org/10.1186/s12885-019-6221-0

Published Online: 2019-11-01

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bolandghamat Pour, Zahra

Nourbakhsh, Mitra http://orcid.org/0000-0002-6716-0354
Mousavizadeh, Kazem

Madjd, Zahra

Ghorbanhosseini, Seyedeh Sara

Abdolvahabi, Zohreh

Hesari, Zahra

Ezzati Mobasser, Samira
Funding

Funding for this research was provided by:

Iran University of Medical Sciences (27355)
License Information

Text and Data Mining valid from 2019-11-01

Version of Record valid from 2019-11-01
More Information

Article History

Received: 16 June 2019

Accepted: 30 September 2019

First Online: 1 November 2019

Ethics approval and consent to participate

: This research was approved by Ethics Committee of Iran University of Medical Sciences and followed the ethics guidelines published by Ministry of Health.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below